Literature DB >> 24896334

TNF/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases.

George Priya C Doss1, Govindasamy Agoramoorthy1, Chiranjib Chakraborty1.   

Abstract

Tumor necrosis factor, a regulatory cytokine, is extremely important signaling protein in the immune system. Among TNF family, TNF-alpha, TNF-beta are most the significant family members. Receptor of TNF namely TNFR1 and TNFR2 stimulates two different signaling pathways. TNFR1 signaling induces apoptosis pathway. Conversely, TNFR2 signaling triggers cell survival pathways. In this paper, we discuss about the TNF family with special reference to TNF-alpha/TNF-beta, different hypothesis related to autoimmunity and role of TNF, structure of TNF-alpha/TNF-beta, distribution and normal activity in human body of TNF, receptors and signaling pathway for drug targeting. Finally, we also discuss about the therapy for autoimmune diseases and immune-mediated inflammatory diseases (IMIDs) using small molecules or therapeutic proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24896334     DOI: 10.2741/4265

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  12 in total

1.  2K1C-activated Angiotensin II (Ang II) exacerbates vascular damage in a rat model of arthritis through the ATR/ERK1/2 signaling pathway.

Authors:  Ying Zhang; Xuexia Luo; Yue Zhou; Huaxun Wu; Jingyu Chen; Ying Wang; Danian Chen; Zhouwei Xu; Shangxue Yan; Wei Wei
Journal:  Inflamm Res       Date:  2017-06-26       Impact factor: 4.575

Review 2.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

3.  Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals.

Authors:  Zhenwei Shang; Hongchao Lv; Mingming Zhang; Lian Duan; Situo Wang; Jin Li; Guiyou Liu; Zhang Ruijie; Yongshuai Jiang
Journal:  Oncotarget       Date:  2015-12-15

4.  Severe erythema multiforme-type drug eruption controlled by tumor necrosis factor-α antagonist: A case study.

Authors:  Xin Ling; Xin Shi; Lingling Chen
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

5.  Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.

Authors:  Sophie Glatt; Dominique Baeten; Terry Baker; Meryn Griffiths; Lucian Ionescu; Alastair D G Lawson; Ash Maroof; Ruth Oliver; Serghei Popa; Foteini Strimenopoulou; Pavan Vajjah; Mark I L Watling; Nataliya Yeremenko; Pierre Miossec; Stevan Shaw
Journal:  Ann Rheum Dis       Date:  2017-12-23       Impact factor: 19.103

6.  The association between TNF-α 238A/G and 308A/G polymorphisms and juvenile idiopathic arthritis: An updated PRISMA-compliant meta-analysis.

Authors:  Xing-Yan Li; Chun-Hua Liang; Virginia Parkman; Zheng-Tao Lv
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  The IKK-binding domain of NEMO is an irregular coiled coil with a dynamic binding interface.

Authors:  Adam H Barczewski; Michael J Ragusa; Dale F Mierke; Maria Pellegrini
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

8.  Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis.

Authors:  Nicole Yang; Jie Huang; Michelle Frits; Christine Iannaccone; Michael E Weinblatt; Nader Rifai; Nancy Shadick; Gary Bradwin; Katherine P Liao
Journal:  Pract Lab Med       Date:  2019-05-03

Review 9.  Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses.

Authors:  Bilgenaz Özkan; Heejin Lim; Sung-Gyoo Park
Journal:  Int J Mol Sci       Date:  2018-05-15       Impact factor: 5.923

Review 10.  Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

Authors:  Przemyslaw J Kotyla
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.